Anna L. David
Has grant
Research Interests
Explore related searches
Contact this professor
Recent Grants
Grant: Close
Rotation of the fetal head at full cervical dilatation
Open Date: 2021-06-01
Close Date: 2025-08-01
Grant: Close
Fetoscopic repair of fetal spina bifida and tracheal occlusion for congental diaphragmatic hernia
Open Date: 2020-11-01
Close Date: 2025-10-01
Grant: Close
COVID-19: Assessing the vulnerability of the fetus to SARS-CoV2 infection across development
Open Date: 2020-06-01
Close Date: 2021-05-01
Grant: Close
Risk of preterm birth in women who conceive following bone marrow transplantation in childhood
Open Date: 2020-01-01
Close Date: 2021-07-01
Grant: Close
PREDICT study: Predicting preterm birth after surgical intervention in twin pregnancies
Open Date: 2019-09-01
Close Date: 2021-08-01
Articles (11)
Year:
2023
Maternal and fetal safety outcomes after in utero stem cell injection: A systematic review
Objective To investigate the maternal and fetal safety of In utero stem cell transplantation (IUSCT). Methods Medline®, Embase and Cochrane library (1967−2023) search for publications reporting IUSCT in humans. Two reviewers independently screened abstracts and full‐text papers. Results Sixty six transplantation procedures in 52 fetuses were performed for haemoglobinopathies ( n = 14), red cell/bleeding disorders ( n = 4), immunodeficiencies ( n = 15), storage disorders ( n = 7), osteogenesis imperfecta ( n = 2) and healthy fetuses ( n = 10). The average gestational age was 18.9 weeks; of procedures reporting the injection route, cells were delivered by intraperitoneal ( n = 37), intravenous ( n = 19), or intracardiac ( n = 4) injection or a combination ( n = 3); most fetuses received one injection ( n = 41). Haematopoietic ( n = 40) or mesenchymal ( n = 12) stem cells were delivered. The cell dose was inconsistently reported (range 1.8−3.3 × 10 9 cells total ( n = 27); 2.7−5.0 × 10 9 /kg estimated fetal weight ( n = 17)). The acute fetal procedural complication rate was 4.5% (3/66); the acute fetal mortality rate was 3.0% (2/66). Neonatal survival was 69.2% (36/52). Immediate maternal and pregnancy outcomes were reported in only 30.8% (16/52) and 44.2% (23/52) of cases respectively. Four fetal/pregnancy outcomes would also classify as ≥ Grade 2 maternal adverse events. Conclusions Short‐, medium‐, and long‐term maternal and fetal adverse events should be reported in all IUSCT studies.
Year:
2023
Cx43 regulates mechanotransduction mechanisms in human preterm amniotic membrane defects
Objective The effects of mechanical stimulation in preterm amniotic membrane (AM) defects were explored. Methods Preterm AM was collected from women undergoing planned preterm caesarean section (CS) due to fetal growth restriction or emergency CS after spontaneous preterm prelabour rupture of the membranes (sPPROM). AM explants near the cervix or placenta were subjected to trauma and/or mechanical stimulation with the Cx43 antisense. Markers for nuclear morphology (DAPI), myofibroblasts (αSMA), migration (Cx43), inflammation (PGE 2 ) and repair (collagen, elastin and transforming growth factor β [TGFβ 1 ]) were examined by confocal microscopy, second harmonic generation, qPCR and biochemical assays. Results In preterm AM defects, myofibroblast nuclei were highly deformed and contractile and expressed αSMA and Cx43. Mechanical stimulation increased collagen fibre polarisation and the effects on matrix markers were dependent on tissue region, disease state, gestational age and the number of fetuses. PGE 2 levels were broadly similar but reduced after co‐treatment with Cx43 antisense in late sPPROM AM defects. TGFβ 1 and Cx43 gene expression were significantly increased after trauma and mechanical stimulation but this response dependent on gestational age. Conclusion Mechanical stimulation affects Cx43 signalling and cell/collagen mechanics in preterm AM defects. Establishing how Cx43 regulates mechanosignalling could be an approach to repair tissue integrity after trauma.
Year:
2023
Year:
2023
Collaborators (13)
Yada Kunpalin
Mount Sinai Hospital
Jan Deprest
-
Simon Waddington
Professor of Gene Therapy
University College London
Amanda Sferruzzi-Perri
University Lecturer in Reproductive Physiology (proleptic appointment)
University of Cambridge
Emily Cornish
NIHR Academic Clinical Lecturer in Obstetrics and Maternal Fetal Medicine Subspecialty Trainee
University College London
Sara Hillman
Associate Professor
University College London
Rebecca Spencer
University of Leeds
Luc Joyeux
Assistant Professor, Attending Pediatric and Fetal Surgeon & Senior research scientist
Baylor College of Medicine
Neil Marlow
Emeritus Professor of Neonatal Medicine
University College London
Andrew Melbourne
King’s College London
Ahad Rahim
University College London
Dimitrios Siassakos
Professor & Consultant in Obstetrics
University College London
Tina T. Chowdhury
-

How do I reach out?
Sign in for free to see their profile details and contact information.